e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pharmacogenetics and asthma: false hope or new dawn?
Hall I. P., Sayers I.
Source:
Eur Respir J 2007; 29: 1239-1245
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hall I. P., Sayers I.. Pharmacogenetics and asthma: false hope or new dawn?. Eur Respir J 2007; 29: 1239-1245
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Asthma: still a promising future?
Source: Eur Respir Rev 2014; 23: 405-407
Year: 2014
What’s new in the epidemiology of asthma?
Source: Virtual Congress 2021 – Paediatric year in review
Year: 2021
The paradoxes of asthma management: time for a new approach?
Source: Eur Respir J, 50 (3) 1701103; 10.1183/13993003.01103-2017
Year: 2017
What’s new in paediatric asthma?
Source: International Congress 2018 – Paediatric Year in Review
Year: 2018
NORDSTAR: paving the way for a new era in asthma research
Source: Eur Respir J, 55 (4) 1902476; 10.1183/13993003.02476-2019
Year: 2020
Paediatric asthma: where to go?
Source: Eur Respir Rev 2012 21:173-174
Year: 2012
Paediatric asthma: where to go?
Source: Annual Congress 2013 –European Respiratory Review: what's hot in pulmonary medicine
Year: 2013
Clinical asthma phenotypes in the real world: opportunities and challenges
Source: Breathe 2015; 11:186-193
Year: 2015
Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015
Resetting the agenda: a new approach to mild asthma
Source: International Congress 2019 – New recommendations and priorities for asthma management
Year: 2019
Applying the 3Rs to asthma research
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Control of asthma in real life: still a valuable goal?
Source: Eur Respir Rev 2015; 24: 361-369
Year: 2015
What is important to people with asthma: Maximising research impact?
Source: International Congress 2015 – Any news from the asthma field?
Year: 2015
International perspectives on severe asthma: Current and future challenges in patient care
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Asthma paradoxes: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 53 (4) 1802329; 10.1183/13993003.02329-2018
Year: 2019
Asthma paradoxes: time for a new approach across the spectrum of asthma severity
Source: Eur Respir J, 53 (4) 1900218; 10.1183/13993003.00218-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept